Incannex Appoints Principal Investigators for IHL-42X Phase 2/3 Clinical Trial

Incannex Healthcare Limited has appointed two principal investigators for its IND opening Phase 2/3 clinical trial, investigating IHL-42X for the treatment of obstructive sleep apnoea (OSA). The lead PIs recruited are Dr John D Hudson of FutureSearch Trials of Neurology, Austin, Texas and Dr Russell Rosenberg of Neurotrials Research Inc, Atlanta, Georgia. Site recruitment and selection in the US..